Fred Alger Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
|
|||||
2023
Q2 | $5.61M | Sell |
|
|||||
2023
Q1 | $13.1M | Sell |
|
|||||
2022
Q4 | $23.2M | Buy |
|
|||||
2022
Q3 | $12.5M | Buy |
|
|||||
2022
Q2 | $6.56M | Buy |
|
|||||
2022
Q1 | $5.31M | Sell |
|
|||||
2021
Q4 | $19.4M | Sell |
|
|||||
2021
Q3 | $28.4M | Buy |
|
|||||
2016
Q4 | – | Sell |
|
|||||
2016
Q3 | $242K | Buy |
|
|||||
2016
Q2 | $234K | Sell |
|
|||||
2016
Q1 | $927K | Sell |
|
|||||
2015
Q4 | $5.34M | Sell |
|
|||||
2015
Q3 | $3.96M | Sell |
|
|||||
2015
Q2 | $13.9M | Sell |
|
|||||
2015
Q1 | $15.5M | Sell |
|
|||||
2014
Q4 | $14.4M | Buy |
|
|||||
2014
Q3 | $8.76M | Sell |
|
|||||
2014
Q2 | $11.6M | Sell |
|
|||||
2014
Q1 | $12.9M | Sell |
|
|||||
2013
Q4 | $25.7M | Buy |
|
|||||
2013
Q3 | $12.6M | Buy |
|